The First 1 ns SLT Device on the Market. Selective Laser Trabeculoplasty (SLT) is an advanced, non-invasive, primary or secondary treatment for elevated intraocular pressure (IOP) in glaucoma. It uses short laser pulses of a specific wavelength to selectively target pigmented cells of the trabecular meshwork without causing extensive thermal damage. Standard SLT uses low-energy laser with a pulse duration of 3–5 ns. This low-energy radiation stimulates the removal of damaged cells by macrophages and increases the porosity of the trabecular meshwork to restore effective drainage of aqueous humour through the drainage angle, resulting in the reduction of IOP to non-pathological levels.
The First Solid-State Diode-Pumped Laser for SLT on the Market. The OptoSLT nano is a new laser technology superior to existing SLT devices. It offers very high pulse-to-pulse stability (±2.5%). By reducing the laser pulse duration to 1 ns without compromising efficacy, this technology allows faster (up to 5 Hz) and safer SLT procedures. With a compact, highly portable design, the OptoSLT nano is an ideal addition to any medical practice. Energy levels range from 0.2 to 2.0 mJ and the 635 nm red diode aiming beam ensures precise focusing for highly predictable and effective treatment every time.
Our company offers FREE technical inspection for all existing equipment of our represented brands.
Advantages: laser light stimulates the body's own healing mechanism to reduce intraocular pressure, effective as primary/adjunctive/repeat treatment, safe…